InsiderClue
Insiders · Profile

Walker Neal

Director at Aclaris Therapeutics · Director at Aldeyra Therapeutics. Filing since 7 May 2014. CIK 0001604457

ACRS Aclaris Therapeutics, Inc. Director · 14 trades ALDX Aldeyra Therapeutics, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
ACRS Aclaris Therapeutics, Inc.
3 Mar 2023
Director
Sold, plan not stated
30,240
$382.07K
2.3%
ACRS Aclaris Therapeutics, Inc.
2 Mar 2023
Director
Sold, plan not stated
29,000
$358.59K
2.2%
ACRS Aclaris Therapeutics, Inc.
2 Feb 2023
Director
Sold, plan not stated
5,000
$81.25K
0.4%
ACRS Aclaris Therapeutics, Inc.
1 Feb 2023
Director
Sold, plan not stated
25,000
$418.68K
2.1%
ACRS Aclaris Therapeutics, Inc.
4 Jan 2023
Director
Sold, plan not stated
15,000
$223.34K
1.2%
ACRS Aclaris Therapeutics, Inc.
3 Jan 2023
Director
Sold, plan not stated
25,000
$381.21K
2.0%
ACRS Aclaris Therapeutics, Inc.
25 Apr 2022
President and CEO
Sold, plan not stated
20,000
$303.66K
1.6%
ACRS Aclaris Therapeutics, Inc.
22 Apr 2022
President and CEO
Sold, plan not stated
25,000
$376.10K
1.9%
ACRS Aclaris Therapeutics, Inc.
21 Apr 2022
President and CEO
Sold, plan not stated
25,000
$380.95K
1.9%
ACRS Aclaris Therapeutics, Inc.
11 Mar 2022
President and CEO
Sold, plan not stated
56,303
$896.05K
4.1%
ACRS Aclaris Therapeutics, Inc.
9 Feb 2022
President and CEO
Sold, plan not stated
3,595
$45.51K
0.3%
ACRS Aclaris Therapeutics, Inc.
2 Jun 2021
President and CEO
Sold, plan not stated
33,260
$719.73K
2.6%
ACRS Aclaris Therapeutics, Inc.
22 Apr 2021
President and CEO
Sold, plan not stated
30,000
$805.24K
2.5%
ACRS Aclaris Therapeutics, Inc.
5 Apr 2018
President and CEO
Bought
10,000
$167.50K
1.1%
ALDX Aldeyra Therapeutics, Inc.
7 May 2014
Director
Bought
6,250
$50.00K
opened
15 decisions on file.